Name: Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche (Video) | JoVE Journal
Uploaded: 2015-03-15T15:00:00.000+00:00
Duration: 11 min 41 s
Description: Learn to culture human femur tissue explants for studying breast cancer cell colonization in the metastatic niche. This method enables analysis of proliferation, migration, and bone microenvironment interactions using bioluminescence and fluorescence imaging techniques.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

These studies were funded, in part, by grants from the Alternative Research and Development Foundation (107588), the National Institute of Health (1U54CA136465-04S1), and the California Breast Cancer Research Program (201B-0141). We thank Drs. Andrew Wilber and R. Scott McIvor for the generous donation of their <pkt2 lubig=""> transponson and pK/hUbiC-SB11 transposase plasmids. We gratefully acknowledge John Tamaresis, Ph.D. for advice on statistical methods, Timothy Brown for performing flow cytometry, Georgette Henrich for advice on migrations assays, and Nancy Bellagamba for facilitating the collection of THR specimens. </pkt2>

Femoral heads were collected from patients undergoing elective THR surgery in the Department of Orthopaedic Surgery at the Stanford University School of Medicine. All tissues were collected as de-identified specimens in accordance with regulations of the Stanford University Research Compliance Office.
&#8203;1. Selecting a Breast Cancer Cell Line(s)
<ol>
	<li>Obtain or transfect the desired breast cancer cell line(s) with a luciferase-GFP reporter construct. The following experiments were performed using the MDA-MB-231 and MCF-7 breast cancer cell lines engineered for the stable expression of firefly luciferase (fLuc) and enhanced green fluorescent protein (EGFP) by transfection with the Sleeping Beauty transposon plasmid pKT2/LuBiG and the transposase plasmid pK/hUbiC-SB1145,46. 
	NOTE: The transfected cell lines are referred to as MDA-MB-231-fLuc-EGFP, and MCF-7-fLuc-EGFP.</li>
</ol>
2. Isolating Tissue Fragments from Femoral Heads
<ol>
	<li>Following THR surgery, collect the discarded femoral head in a sterile container filled with physiological saline. Transfer the specimen to the laboratory and process it within 1-3 hr of surgery. Note: if there is a delay in processing, place the specimen at 4 &#176;C.</li>
	<li>Prepare a working area by placing the following items on an absorbent mat in a laminar flow tissue culture hood: sterile gloves, surgical rongeur, forceps, beaker with 70% isopropanol to rinse instruments, and tissue culture vessels as stipulated below for each type of experiment.</li>
	<li>Wearing a sterile surgical glove to hold the round femur head in one hand, use the rongeur in the other hand to extract trabecular bone fragments of desired size (~2-5 mm) from the exposed upper shaft of the femur. Transfer bone fragments into the culture vessel (e.g., 6-, 12-, or 24-well tissue culture plate or migration chamber), depending on the type of proliferation, colonization or migration experiment, as described in steps 3, 4 or 5. 
	NOTE: Bone tissue fragments should be harvested as described above after completing the initial steps for each specific proliferation, colonization or migration assay. Fragments will range in size as shown in Figure 2. Fragments can be weighed before or after experiments for the purpose of standardization.</li>
</ol>

3. Co-culturing Breast Cancer Cells Adjacent to Bone Fragments to Measure Breast Cell Proliferation Using BLI
<ol>
	<li>Prior to the experiment, prepare a suspension containing 2 x 105 breast cancer cells/50 &#181;l, and prepare plugs of bone wax for immobilizing bone fragments in culture. Cut a P200 micropipette tip into 3 pieces and use the narrow end of the largest piece in a &#8220;cookie cutter&#8221; manner to cut small (~35 mg) pieces of bone wax. Use the wide end of the smallest piece to eject the bone wax plugs into a Petri dish for storage.</li>
	<li>Place a piece of bone wax at the 12 o&#8217;clock position of each well and gently press down with a sterile-gloved index finger.</li>
	<li>Pipette 50 &#181;l of cell suspension containing 1 x 105 breast cancer cells in DMEM-10% FBS + Pen-Strep in the center of each well of a 6-well plate. (Alternatively, seed cells in a dispersed pattern if desired.) Place the plate in a 37 &#176;C tissue culture incubator for 45 min to promote cell attachment.</li>
	<li>Place 1 bone fragment onto 1 piece of bone wax for each experimental well and apply gentle pressure with the rongeur to secure it. Perform experiments in triplicate such that 3 bone fragments from a given THR specimen are placed into the top three wells, while the bottom three wells contain bone wax only as controls.</li>
	<li>Using a 5 ml pipette, gently and slowly deliver 5 ml of DMEM-10% FBS to the side of each well to avoid dislodging the breast cells or bone fragments. Place the plate in a 37 &#176;C tissue culture incubator for 20-24 hr.</li>
	<li>To perform bioluminescence imaging (BLI) remove the plate from the incubator and add luciferin substrate (to achieve a concentration of 300 &#181;g/ml) to each well. Image the plate immediately on an IVIS Imaging Platform using the following parameters: f-stop of 1, small binning, exposure time of 1 sec, level D. Measure the signal intensity of each well as average radiance (photons/second/square centimeter/steradian).</li>
	<li>Use imaging software to define Regions of Interest (ROI) to quantitate the average radiance for all experimental and control wells. Export average radiance values to an Excel sheet to perform statistics and generate graphs.</li>
</ol>
4. Co-culturing Breast Cancer Cells Seeded Directly Onto Bone Fragments to Study Colonization and Cell Number
<ol>
	<li>Use forceps to place bone fragments directly into the empty wells of a 24-well tissue culture plate (1 fragment/well).</li>
	<li>Pipette a 50 &#181;l cell suspension droplet of DMEM-10% FBS containing 1 X 103-6 breast cancer cells directly on top of each bone fragment. Place the plate in a 37 &#176;C tissue culture incubator for 45 min to promote cell attachment. Gently add 1-2 ml DMEM-10% FBS into the side of each well such that the fragment is entirely submerged in medium. Incubate the plate in a 37 &#176;C tissue culture incubator for 20-24 hr.</li>
	<li>After incubation, use forceps to transfer each bone tissue fragment to a fresh 24-well plate containing 1 ml DMEM-10% FBS in each well. To perform BLI, follow steps 3.6-3.7 above. Additionally, fragments may be viewed using a fluorescence microscope, or flushed to obtain the marrow population for analyses of breast cancer cell numbers and properties as described in step 6.</li>
	<li>To prepare the intact fragments for qualitative evaluation by fluorescence microscopy following BLI, pipette 5 &#181;l of fluorescent bisphosphonate labeling solution (prepared according to the manufacturer&#8217;s instructions) into each well to label the mineralized spicules of the bone fragments. Incubate the plate in the tissue culture incubator for another 24 hr.</li>
	<li>Following 24 hr of culture in fluorescent bisphosphonate labeling solution, use forceps to transfer the fragments to tissue culture plates containing phenol red-free medium and view using a fluorescence microscope configured to image GFP (485 nm) and bisphosphonate label (680 nm).</li>
</ol>
5. Measuring Migration of Breast Cancer Cells to Bone Tissue Fragments and Cultured Bone Fragment Supernatants
<ol>
	<li>Migration toward bone tissue culture supernatant. 
	NOTE: Perform experiments in triplicate such that 3 fragments from a given THR specimen are used to generate 3 supernatants. For each experiment, migration is compared across three wells containing bone supernatants vs. three wells containing control medium only.
	<ol>
		<li>Generate bone tissue supernatants by placing bone fragments into the wells of a 12-well plate containing 2.2 ml DMEM-10% FBS per well. Culture in a 37 &#176;C tissue culture incubator for 24 hr. Withdraw the medium at 24 hr and replace with 2.2 ml fresh DMEM-10% FBS. Treat control wells containing DMEM-10% FBS the same way. 
		NOTE: The medium is changed at 24 hr to remove factors secreted in response to tissue trauma resulting from surgery. Because bone tissue supernatants are generated in FBS-containing medium, wells containing FBS-containing medium only are included to control for the contributions of FBS to breast cancer cell migration.</li>
		<li>At 48 hr, collect 0.9 ml of each supernatant/control medium and pipette into the wells of a receiver plate. The inserts will later be placed into these wells. Incubate the receiver plate in the tissue culture incubator while seeding the inserts. Note: The remaining supernatant (~1 ml after evaporation) can be collected for analysis of secretome factors if desired44.</li>
		<li>To seed the Transwell inserts, place them into a standard, empty 24-well tissue culture plate. Pipette 350 &#181;l cell suspension containing 1 x 105 breast cancer cells in DMEM-10% FBS onto the upper, inner membrane surface of each insert as shown in Figure 1A. Place the 24-well plate containing the seeded inserts into the 37 &#176;C tissue culture incubator for 45 min to promote attachment.</li>
		<li>Once the cells have attached to the inserts, use forceps to transfer the inserts to the receiver plate according to the manufacturer&#8217;s instructions. Angle each insert when placing it into the receiver well to prevent bubble formation between the insert membrane and the receiver well supernatant. Incubate the receiver plate with inserts for 20 hr in a 37 &#176;C tissue culture incubator. 
		NOTE: Check the bottom side of the receiver plate for bubbles between the insert membrane and the receiver well supernatant. If bubbles are visible, remove the specific inserts and place them again into the receiver well until no bubbles are present.</li>
		<li>After 20 hr use forceps to remove the inserts from the receiver plate. Using the procedures in steps 3.6-3.7 perform BLI to image the cells that have migrated into and attached to the bottom of the receiver plate wells.</li>
	</ol>
	</li>
	<li>Migration toward bone tissue fragments. 
	NOTE: Perform experiments in triplicate such that 3 fragments from a given THR specimen are placed into 3 separate inserts, and 3 glass beads are placed into 3 separate inserts as controls.
	<ol>
		<li>Prepare the receiver plate by pipetting 0.9 ml DMEM-10% FBS into each well. Place it into the tissue culture incubator while preparing the inserts.</li>
		<li>To seed the inserts, invert them on the surface of a plastic microfuge tube box that has a lid. Pipette a 50 &#181;l cell suspension droplet of DMEM-10% FBS containing 1 x 105 breast cancer cells directly onto the outer, bottom surface of each insert membrane (which is facing up on the inverted inserts). Cover the microfuge tube box with the lid cracked open and transfer it to the 37 &#176;C tissue incubator for 45 min to promote cell attachment.</li>
		<li>Transfer the microfuge tube box to the tissue culture hood, and use forceps to turn the seeded inserts right side up and transfer them into the wells of the receiver plate. Pipette 0.450 ml DMEM-10% FBS into each insert cup. Using forceps, transfer one bone tissue fragment (~3 mm) into each prepared insert cup. Optionally, use glass beads as negative controls in additional wells. Place the plate in a tissue culture incubator for 20 hr.</li>
		<li>To measure migration, prepare a standard 24-well tissue culture plate containing 1 ml DMEM-10% FBS per well. Remove the receiver plate from the incubator and use forceps to transfer the bone fragments and beads from each insert into separate wells of the standard plate. Add luciferin substrate (to achieve a final concentration of 300 &#181;g/ml) to each well and perform BLI using the procedures in steps 3.6-3.7.</li>
	</ol>
	</li>
</ol>
6.&#160;Additional Pre- and Post-experimental Analyses
<ol>
	<li>Analysis of flushed marrow.
	<ol>
		<li>Transfer a bone fragment into a 70 &#181;m cell strainer placed at the top of a 50 ml conical tube. Use a 10 ml syringe with a 25 G needle to vigorously flush the fragment with 10 ml of PBS to obtain a suspension of marrow cells in the conical tube. Centrifuge the cell suspension for 3 min at 300 x g and 21 &#176;C, aspirate the supernatant and resuspend the pelleted cells in PBS or other desired solution for flow cytometry. 
		NOTE: Resuspension volumes will vary depending on the size of the cell pellet after centrifugation, and application.</li>
		<li>For viability assays ~75-300 &#181;l volumes of PBS are appropriate, and these suspensions can be analyzed using commercially available fluorescence based viability assays according to the manufacturer&#8217;s instructions, pipetted into a conventional hemocytometer, and counted using an inverted fluorescence microscope.</li>
		<li>For flow cytometric analysis or sorting based on detection of GFP-positive breast cancer cells, resuspend the cell pellet in 1 ml PBS containing 2% FBS, 2mM EDTA, and 10 mM HEPES such that the concentration is 1 x 106 cells/ml.</li>
	</ol>
	</li>
	<li>H &#38; E Staining and Immunohistochemistry.
	<ol>
		<li>To process the fragments for hematoxylin &#38; eosin (H&#38;E) staining and/or immunohistochemistry, place the fragments in plastic cassettes labeled with a number 2 pencil, and submerge in a container filled with 10% buffered formalin for 24 hr.</li>
		<li>Process tissues for paraffin embedding, sectioning and staining using routine protocols that include a decalcification step to account for the mineralized spicules within each fragment.</li>
	</ol>
	</li>
</ol>

No disclosures to report.

Mehra et al. have previously described the postmortem collection and analysis of bone specimens from metastatic prostate cancer patients harvested at the time of autopsy, revealing high quality tissues and validating the use of human bone samples to study the metastatic process47. Here we have described protocols for collecting, processing and using human bone tissue fragments obtained from discarded femoral heads following THR surgery in a short-term co-culture system to study breast cell migration, ...

The tumor microenvironment is widely recognized as a critical determinant of cancer cell behavior during breast cancer progression and metastatic spread1-3. The goal of the method presented here is to facilitate the study of breast cancer cells within the microenvironment of human bone tissue, the most frequent site of breast cancer metastasis4-6. Bone is comprised of mineralized and marrow compartments7-9, both of which harbor cells and secreted factors implicated in metastatic progression10,11. Although widely used in vivo mouse models facilitate systemic studies of the metastatic process12-15, cell interactions within the skeleton are not readily accessible for observation and direct perturbation. Model systems for studying and culturing mouse bone tissues and mouse marrow cells provide better access and have yielded many insights regarding crosstalk and mechanisms underlying breast cancer cell metastasis of the murine skeleton16-22. However, studies have suggested that there may be species-specific patterns of osteotropism for bone tissue23,24. These patterns could reflect inherent species-specific differences in bone tissue properties, differences resulting from altered bone marrow populations in immune-deficient mice11, and/or the relatively young age of mice used in experiments, all of which are likely determinants of the bone microenvironment.
In vitro approaches for studying breast cancer cells in human bone co-cultures have typically focused on specific bone cell types such as marrow-derived osteoblasts or stromal cells cultured as monolayers or within engineered 3-dimensional model systems25-35. Although 2-dimensional cell culture models have formed the mainstay of in vitro approaches for cancer research, it has long been recognized that cell behavior is fundamentally altered in monolayer culture systems18,36,37. This has led to the development of engineered microenvironments that mimic the complexity of 3-dimensional living tissues, including matrix- and scaffold-based models composed of natural materials such as collagen, or synthetic polymers seeded with specific cell types to create tissue-like microenvironments36-41. Engineered approaches have also included the use of bioreactor platforms to control and study the hormonal milieu of the microenvironment18,19,41-43. Although biomimetic models and bioreactors provide many elements of a complex tissue microenvironment in a controlled setting, and have been successfully applied to advance the study of breast cancer metastasis to bone18,19,35,42,43, engineered model systems do not generally incorporate the full spectrum of cell types and extracellular matrix components present within the native bone environment.
Until recently, breast cancer cells have not been studied within the native, intact, 3-dimensional microenvironment of human bone tissues. We recently reported the development of a co-culture model using human bone tissue fragments isolated from total hip replacement (THR) surgery specimens44. These specimens harbor both the mineralized and marrow compartments necessary to study mechanisms underlying micro-metastasis in short term culture. In previous work we established proof-of-principle for using bioluminescence imaging (BLI) to monitor the proliferation of luciferase-expressing breast cancer cells (MDA-MB-231-fLuc) co-cultured with bone fragments44. Here we present detailed experimental protocols for studying breast cell cancer proliferation, colonization, and migration within the context of the native microenvironment using human bone tissue explants.
First we present a protocol for co-culturing breast cancer cells adjacent to bone fragments to measure breast cell proliferation using BLI. In this section, breast cell suspensions are seeded as cell spots in 6-well plates adjacent to bone fragments, which are immobilized by pieces of bone wax. Control wells contain bone wax, but no bone fragment. Once cell spots attach, medium is added and the plate is cultured for 24 hr, after which bioluminescent signal intensity (associated with cell number) is measured with BLI. In the next step we present methods for co-culturing breast cancer cells seeded directly onto bone fragments to study colonization and proliferation. Here the breast cell suspensions are pipetted directly onto the bone tissue fragments, which are monitored in culture by BLI and fluorescence microscopy over time to track colonization and cell number. In this method, the marrow compartment can be flushed from the bone fragments at any time point for analysis of colonized breast cancer cells by flow cytometry, or marrow viability assays.
In addition, we describe two different approaches for measuring breast cancer cell migration. In the first method steps are outlined for measuring migration toward bone tissue culture supernatants. In this protocol the breast cancer cells are seeded onto the inner, upper surfaces of Transwell insert membranes with an 8 &#181;m pore size (as shown in Figure 1A). The inserts are then placed into a receiver plate with wells containing bone tissue supernatant or control medium. Over the course of a 20 hr incubation period, small numbers of breast cancer cells migrate through the insert membranes down into the lower tissue culture wells where they attach for detection by BLI. In the second migration method the breast cancer cells are seeded onto the lower, outer surfaces of Transwell insert membranes. Bone tissue fragments are placed into the insert cups and the breast cancer cells migrate up through the membranes to colonize the bone fragments (as shown in Figure 1B), which are then imaged using BLI.

<table><tbody><tr><td>DMEM (1X) + GlutaMAX-l</td><td>Life Technologies</td><td>10569-010</td><td>Supplement all DMEM with 10% fetal bovine serum and 1% Pen/Strep</td></tr><tr><td>McCoy&#039;s 5A Medium (1X)</td><td>Life Technologies</td><td>16600-082</td><td>Supplement all McCoy&#039;s&amp;nbsp; with 10% fetal bovine serum and 1% Pen/Strep</td></tr><tr><td>Fetal bovine serum</td><td>Life Technologies</td><td>16000-044</td><td></td></tr><tr><td>Penicillen Streptomycin</td><td>Life Technologies</td><td>15140-122</td><td></td></tr><tr><td>Blastocidin (10 mgl/ml)</td><td>InvivoGen&amp;nbsp;</td><td>ant-bl</td><td>Supplement media used for transfected cell lines.</td></tr><tr><td>Falcon&amp;reg; Cell Culture Inserts for 24 Well Plate with Transparent PET Membrane (8.0 &amp;mu;m pore size)</td><td>Corning Incorporated</td><td>353097</td><td></td></tr><tr><td>Falcon&amp;reg; 24 Well TC-Treated Polystyrene Cell Culture Insert Companion Plate</td><td>Corning Incorporated</td><td>353504</td><td></td></tr><tr><td>LIVE/DEAD Viability/Cytotoxicity Kit *for mammalian cells*</td><td>Invitrogen Detection Technologies</td><td>L-3224</td><td></td></tr><tr><td>FluoroBrite DMEM</td><td>Life Technologies</td><td>A18967-01</td><td></td></tr><tr><td>D-luciferin firefly, potassium salt 5 g (30 mg/ml)</td><td>Life Technologies</td><td>L-8220</td><td></td></tr><tr><td>Sterile Cell Strainer 70 &amp;mu;m</td><td>Fisher Scientific</td><td>22363548</td><td></td></tr><tr><td>6 Well TC-Treated Cell Culture Cluster</td><td>Corning Incorporated</td><td>3516</td><td></td></tr><tr><td>12 Well TC-Treated Cell Culture Cluster</td><td>Corning Incorporated</td><td>3513</td><td></td></tr><tr><td>24 Well TC-Treated Cell Culture Cluster</td><td>Corning Incorporated</td><td>3526</td><td></td></tr><tr><td>Friedman-Pearson Rongeur</td><td>Fine Science Tools</td><td>16021-14</td><td></td></tr><tr><td>Bone wax</td><td>Surgical Specialties Corporation</td><td>903</td><td></td></tr><tr><td>IVIS 50 Imaging Platform</td><td>Caliper Life Sciences/PerkinElmer</td><td></td><td></td></tr><tr><td>Living Image Software Program&amp;nbsp;</td><td>Caliper Life Sciences/PerkinElmer</td><td>133026</td><td></td></tr><tr><td>EVOS FL Imaging System</td><td>Life Technologies</td><td>Version 4.2</td><td></td></tr><tr><td>OsteoSense 680 EX</td><td>PerkinElmer</td><td>NEV10020EX</td><td></td></tr><tr><td>MCF-7 breast cancer cells</td><td>ATCC</td><td>HTB-22</td><td></td></tr><tr><td>MDA-MB-231 breast cancer cells</td><td>ATCC</td><td>HTB-26</td><td></td></tr><tr><td>Monoclonal mouse anti-human cytokeratin antibody</td><td>DAKO Cytomation</td><td>Clone (AE1/AE3)</td><td></td></tr></tbody></table>

methods for culturing human femur tissue explants to study breast cancer cell colonization of the metastatic niche

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Bone is the most common site of breast cancer metastasis. Although it is widely accepted that the microenvironment influences cancer cell behavior, little is known about breast cancer cell properties and behaviors within the native microenvironment of human bone tissue.We have developed approaches to track, quantify and modulate human breast cancer cells within the microenvironment of cultured human bone tissue fragments isolated from discarded femoral heads following total hip replacement surgeries. Using breast cancer cells engineered for luciferase and enhanced green fluorescent protein (EGFP) expression, we are able to reproducibly quantitate migration and proliferation patterns using bioluminescence imaging (BLI), track cell interactions within the bone fragments using fluorescence microscopy, and evaluate breast cells after colonization with flow cytometry. The key advantages of this model include: 1) a native, architecturally intact tissue microenvironment that includes relevant human cell types, and 2) direct access to the microenvironment, which facilitates rapid quantitative and qualitative monitoring and perturbation of breast and bone cell properties, behaviors and interactions. A primary limitation, at present, is the finite viability of the tissue fragments, which confines the window of study to short-term culture. Applications of the model system include studying the basic biology of&#160;breast cancer and other bone-seeking malignancies within the metastatic niche, and developing therapeutic strategies to effectively target breast cancer cells in bone tissues.

Isolating Tissue Fragments from Femoral Heads
Femoral heads were collected from equal numbers of male and female patients (44-90 years of age) undergoing elective total hip replacement surgery in the Department of Orthopaedic Surgery at the Stanford University School of Medicine. Each discarded femoral head contains a small portion of the upper femur, which harbors trabecular bone tissue composed of mineralized spicules and marrow. This tissue is accessible through the surgically exposed cross...

Protocols are described for studying breast cancer cell migration, proliferation and colonization in a human bone tissue explant model system.

Bone is the most common site of breast cancer metastasis. Although it is widely accepted that the microenvironment influences cancer cell behavior, little ...

The goal of this procedure is to study breast cancer cell proliferation, colonization, and migration in a human bone tissue explan model system. This is accomplished by isolating trabecular bone tissue fragments from femoral head surgical specimens and culturing them with breast cancer cells expressing luciferase and green fluorescent protein. Bioluminescence imaging is used to measure proliferation of cells and verify the colonization of breast cancer cells in the bone tissue fragments.Patterns of breast cancer cell colonization are imaged by fluorescence microscopy. The marrow compartment can be flushed from the fragments for analysis by flow cytometry by luminescence and staining assays. Breast cancer cell migration towards tissue culture, supernatants and bone tissue fragments is measured in Transwell migration chambers with bioluminescence imaging bone is the most frequent site of breast cancer metastasis, and ultimately this model provides a new window for studying breast cancer cells within the bone metastatic niche.A big advantage of this model is that it provides direct access to the microenvironment of human bone tissue fragments, allowing us to easily observe and analyze breast cancer cell behavior during short term co culture experiments. This method can be used to study key questions about mechanisms underlying breast cancer, metastas to bone with the goal of identifying therapeutic strategies to effectively prevent and treat it action. Although this model can provide insight into breast cancer metastasis, it can also be used to study other bone seeking malignancies, such as prostate cancer.Bone tissue fragments must be harvested at various points in each assay. This begins with collecting and transporting a femoral specimen in saline and preparing the workstation in a biosafety cabinet wearing a surgical glove. Take hold of the femur head in one hand and use a surgical raw to extract trabecular bone.Fragments show about two to five millimeters in size. Forceps won't work for this step. You need a good quality surgical raw.For this experiment, prepare a breast cancer cell suspension with 100, 000 cells per 50 microliters of DMEM plus 10%FBS. In addition, prepare plugs of bone wax for mobilizing the bone fragments using the cutoff ends of a micro pipette tip, store the plugs in a Petri dish. Then with forceps, transfer the plugs into a six well plate and using a sterile glove, press the plugs into the 12 o'clock position.Next pipette 50 microliters of the cell suspension into the center of each. Well place the plate in a tissue culture incubator for 45 minutes to promote cell attachment while the plate incubates extract the bone fragments with the cells attached to the plate. Place a bone tissue fragment onto the bone wax in three wells and press each down using the GER three wells without fragments servers controls.Next, slowly add five milliliters of DMEM plus 10%FBS to the wall of each well. The bone wax and bone fragments mustn't be dislodged. Then incubate the culture for 20 to 24 hours.The next day image the cells first. Add 300 micrograms per milliliter of Lucifer to each well, and then immediately image the plate with an Ivis imaging platform. This experiment requires a breast cancer cell suspension like the previous one.After extracting bone fragments, use forceps to transfer each fragment to an empty well of a 24 well plate, then pipette 50 microliters of cell suspension directly onto each bone fragment, and transfer the plate to an incubator for 45 minutes to promote cell attachment. Once the cells have attached gently add one to two milliliters of medium to each well enough to submerge the bone fragment. Then place the plate in the tissue culture incubator for 20 to 24 hours.In preparation for Ivis imaging, fluorescence imaging or collecting marrow cells for analysis for Ivis imaging, transfer the bone fragments to a 24 well plate with one milliliter of fresh medium per well. Add 300 micrograms per milliliter Lucifer to each well and proceed as previously described for fluorescence microscopy. Pipette five microliters of fluorescent bisphosphate labeling solution into each well to label the bony spicules of the bone fragment and incubate the plate for another 24 hours.24 hours later, use forceps to transfer the fragments to plates containing phenol red free medium. Then view the plates using a fluorescence microscope configured to image at 485 nanometers to localize colonize GFP expressing breast cancer cells and a 680 nanometers. To identify bisphosphate labeled bone spicules to flush the bone marrow compartment for analysis of cell numbers or properties.Transfer a fragment to a 70 micron strainer over a 50 milliliter chronicle tube tube. Then use a 10 milliliter syringe with a 25 gauge needle to vigorously flush the fragment with 10 milliliters of PBS centrifuge. The suspension at 300 G for three minutes at room temperature to pellet the cells aspirate and discard the supinate reus.Bend the pellet of marrow cells in PBS or other desired solutions per flow cytometry or viability assays. Begin by generating bone tissue snet. Place bone fragments into the wells of a 12.Well plate containing 2.2 milliliters of DMEM 10%FBS per well and leave some control wells without bone fragments. Culture the plate for 24 hours. Then aspirate and replace the medium and continue the culture for another 24 hours, 48 hours into the culture transfer 0.9 milliliters of supinate to a receiver plate while temporarily incubating the receiver plate.Place transwell inserts into an empty 24 well plate. Then iPet 100, 000 breast cancer cells in 350 microliters onto each insert. Then culture the plates for 45 minutes to promote cell attachment After 45 minutes, use forceps to transfer the inserts to a receiver plate.Be sure to angle the inserts when placing them into the receiver. Well supinate so bubbles do not form. Then incubate the plate with inserts for 20 hours at 37 degrees Celsius the next day.Use forceps to remove the inserts and add 300 micrograms per milliliter Lucifer in to each. Well perform bioluminescence imaging on the receiver plate to detect breast cancer cells that have migrated through the membranes and attached to the bottom of the receiver plate wells. First, load a receiver plate with medium and place it in the tissue culture incubator.To seed the inserts. Invert them in an empty micro fused tube box with a lid. Then add 100, 000 cells in 50 microliters to the outer bottom surface of each insert membrane.Cover the box leaving the lid cracked and incubate the inserts for 45 minutes in the tissue culture incubator. Then use forceps to invert and transfer the inserts, the wells of a receiver plate into each insert cup at 0.45 milliliters of DMEM with 10%FBS. Then add a three millimeter bone fragment or glass bead to each insert and cut to the plate for 20 hours.The next day use forceps to transfer the fragments and beads to a plate with wells containing a milliliter of fresh medium. Add 300 micrograms per milliliter Lucifer per well and proceed with bioluminescence imaging. MDA MB 2 31 F.Luke EGFP.Breast cancer cells were co cultured adjacent to immobilized bone fragments to measure breast cell proliferation. Bioluminescence imaging after 24 hours of culture showed enhanced breast cancer cell proliferation in the presence of bone fragments in the top three wells compared to the absence of bone fragments in the bottom three wells. The results of experiments using fragments from three separate surgical specimens showed enhanced proliferation in the presence versus the absence of bone.In all three cases, colonization of MCF seven F Luke EGFP cells seated directly under bone tissue fragments was observed with bioluminescence imaging after 24 hours. Decreased signal was associated with declining seeding density after 48 hours. Directly seeded fragments labeled with bisphosphonate reagent revealed colonization of the GFP positive breast cancer cells within the mineralized and marrow compartments.Migration of the breast cancer cells across the porous migration membrane toward bone tissue culture, supernatants seen in the top three wells was robust compared to migration into control. Medium seen in the bottom three wells. Migration into three bone fragments from a given THR specimen was also observed, whereas no migration onto the beads was observed.After watching this video, you should have a good understanding of how to extract human bone tissue fragments from a femoral head specimen and initiate them into co culture assays to measure breast cancer cell behaviors including migration, colonization and proliferation.

methods-for-culturing-human-femur-tissue-explants-to-study-breast

Research

JoVE Journal

Medicine

We have developed a collagen-based in vitro assay which promotes proliferation and invasion from samples of all breast cancer subtypes. Optical Projection Tomography, a three dimensional microscopy technique was utilised to visualise and quantify tumour expansion. This assay may be used to quantify drug response of individual tumour samples.

Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography

This video describes the culturing of breast cancer cells adjacent to femur bone explants to measure cancer cell proliferation and colonization in a human bone tissue explant model system.

Co-culturing BC Cells: Culturing Breast Cancer Cells with Bone Fragments to Study Cancer Cell Proliferation

In standard culture methods cells are taken out of their physiological environment and grown on the plastic surface of a dish. To study the behavior of primary human bone marrow cells we created a 3-D culture system where cells are grown under conditions recapitulating the native microenvironment of the tissue.

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

Primary cell culture using intact tissue organoids provides a model system that mimics the multi-cellular in vivo microenvironment. We developed a serum-free primary breast epithelium tissue culture model that perpetuates mixed cell culture lineages and exhibits differentiated morphology, without enzymatic tissue disruption. Breast organoids remain viable for &gt;6 months.

Non-enzymatic, Serum-free Tissue Culture of Pre-invasive Breast Lesions for Spontaneous Generation of Mammospheres

Here we present a protocol to co-culture in three-dimensions, which is useful for investigating multicellular interactions and extracellular matrix-dependent modulation of cancer cell behavior. In this experimental model, cancer cells are cultured on collagen gels embedded with human cancer-associated fibroblasts.

Three-dimensional Co-culture Model for Tumor-stromal Interaction

This manuscript describes an ex vivo model system comprised of organ-conditioned media derived from the lymph node, bone, lung, and brain of mice. This model system can be used to identify and study organ-derived soluble factors and their effects on the organ tropism and metastatic behavior of cancer cells.

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Cancer cells are embedded in a collagen gel and then sandwiched in an acellular fibrin gel to generate a 3D culture system in which the invasiveness and formation of satellite tumors may be monitored.

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation

This experimental protocol describes the isolation of BCSCs from breast cancer cell and tissue samples as well as the in vitro and in vivo assays that can be used to assess BCSC phenotype and function.

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

The manuscript describes a methodology for the establishment as well as longitudinal growth monitoring of spontaneous lung metastasis from orthotopically-injected breast tumors, amenable to intervention at all stages of the metastatic cascade.

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

There is a critical need for 3D cancer models that capture heterocellular crosstalk to study cancer metastasis. Our study presents the generation of heteromulticellular stromal-epithelial in a scaffold and scaffold-free environment that can be used to study invasion and cellular spatial distributions.

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

This protocol outlines methods to culture, manipulate, and analyze murine CAFs, including in vitro/in vivo functional assays, transcriptomics, and computational analysis. Moreover, it describes a web-based platform developed to analyze the publicly available transcriptomes of laser capture micro-dissected stromal and epithelial components from a collection of human breast cancer tumors.

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Learn to culture human femur tissue explants for studying breast cancer cell colonization in the metastatic niche. This method enables analysis of proliferation, migration, and bone microenvironment interactions using bioluminescence and fluorescence imaging techniques.

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Explore More Videos